文献速递银屑病与炎症性皮肤病

银屑病患者接受富马酸酯治疗相关的进行性多灶性白质脑病

Progressive multifocal leukoencephalopathy associated with fumaric acid esters treatment in psoriasis patients.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2017-04-25

该系统综述通过检索多个数据库至2016年2月25日,纳入8例银屑病患者接受富马酸酯(FAE)治疗后发生进行性多灶性白质脑病(PML)的病例。所有病例均与绝对淋巴细胞计数中重度降低相关,中位FAE治疗 duration 为3年。推荐定期监测淋巴细胞计数,并在中重度淋巴细胞减少时停用FAE以降低PML风险。

要点

  • FAE相关PML罕见但可能被漏报,医生需警惕新发神经系统症状。
  • 所有报告病例均伴随绝对淋巴细胞计数中重度降低(最低值200–792 cells/mm³)。
  • 建议定期监测淋巴细胞计数,中重度淋巴细胞减少时停用FAE。

核心结论

  • PML与FAE治疗关联不常见,但不能排除漏报可能。
  • 医生和患者应警惕新发神经系统症状,定期监测淋巴细胞计数。

研究设计与样本

  • 系统文献检索多个数据库至2016年2月25日,纳入银屑病患者接受FAEs治疗后发生PML的报告。
  • 共识别8例FAE相关PML病例(4男4女),中位年龄64岁(范围42–74岁)。

主要发现

  • 中位FAE治疗 duration 为3年(范围1.5–5年);6例使用含富马酸二甲酯(DMF)和单乙基富马酸盐的制剂,2例使用DMF制剂。
  • 患者出现失语、偏瘫和构音障碍等神经系统症状;PML诊断基于MRI表现及脑脊液和/或脑组织中JC病毒存在。
  • 所有病例均与绝对淋巴细胞计数中重度降低相关,最低值范围200–792 cells/mm³;中位淋巴细胞减少暴露时间为2年(范围1–5年)。
  • 所有病例停用FAE,并使用甲氟喹加米氮平治疗PML;3例改善,2例稳定,2例残留症状,1例死于免疫重建炎症综合征。

关键数值与推荐

  • 推荐定期监测淋巴细胞计数,并在中重度淋巴细胞减少时停用FAE以最小化PML风险。

临床怎么用

  • 治疗银屑病患者的医生应警惕PML发生,临床医生和患者需注意新发神经系统症状的出现。
  • 对接受FAE治疗的患者定期监测淋巴细胞计数,中重度淋巴细胞减少时停用FAE。

局限性

  • 不能排除PML漏报的可能性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fumaric acid esters (FAEs) are a systemic treatment for psoriasis considered to have a favourable long-term safety profile without an increased risk for immunosuppression. However, progressive multifocal leukoencephalopathy (PML), a rare, opportunistic viral infection of the central nervous system, has been linked anecdotally to FAE treatment. OBJECTIVE: To assess clinical features and outcomes of FAE-associated PML cases. METHODS: Systematic literature search in multiple databases up to 25th February 2016 for reports of PML in psoriasis patients treated with FAEs. RESULTS: Eight cases (four male, four female) of FAE-associated PML were identified. Median age was 64 years (range 42-74 years); median FAE treatment duration was 3 years (range 1.5-5 years). Six patients were treated with a formulation containing dimethyl fumarate (DMF) and monoethyl fumarates, and two patients with a DMF formulation. Patients exhibited neurological symptoms, such as aphasia, hemiparesis and dysarthria. PML diagnosis was based on MRI findings and presence of JC virus in cerebrospinal fluid and/or brain tissue. All cases were linked to moderate-to-severe reductions in absolute lymphocyte counts, with nadirs ranging from 200 to 792 cells per mm3 . Median exposure to lymphocytopenia was 2 years (range 1-5 years). In all cases, FAE treatment was discontinued; PML was treated with mefloquine plus mirtazapine. Three patients improved, two had stable disease, two had residual symptoms, and one patient died to an immune reconstitution inflammatory syndrome. CONCLUSION: Progressive multifocal leukoencephalopathy is infrequently linked to FAE treatment, but underreporting cannot be excluded. Physicians treating patients with FAEs should be vigilant for the occurrence of PML, and both clinicians and patients should be alert for onset of new neurological symptoms. Periodic monitoring of lymphocyte counts and FAE discontinuation in case of moderate-to-severe lymphocytopenia is recommended to minimize the risk for PML.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Balak DMW, Hajdarbegovic E, Bramer WM, et al. Progressive multifocal leukoencephalopathy associated with fumaric acid esters treatment in psoriasis patients. J Eur Acad Dermatol Venereol. 2017. PMID: 28322482. doi:10.1111/jdv.14236

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。